Trafficking of FoxP3+ regulatory T cells:: myths and facts

被引:9
作者
Kim, Chang H. [1 ]
机构
[1] Purdue Univ, Dept Comparat Pathobiol, Lab Immunol & Hematopoiesis, W Lafayette, IN 47907 USA
关键词
FoxP3; regulatory T cells; migration; chemokine receptor; integrin; selectin;
D O I
10.1007/s00005-007-0024-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Fork head box P3 (FoxP3(+)) regulatory T cells (Tregs) are specialized T cells for prevention of hyperimmune responses and autoimmunity. Tumors and pathogens can hijack FoxP3(+) Tregs to evade host immune responses. There is an increasing body of evidence that trafficking of FoxP3(+) Tregs is important for their effective suppression of target cells. Because of their distinctive functions and gene expression phenotype, the migratory behavior of FoxP3(+) Tregs has been somewhat mystified. The myths are that they have unique trafficking receptors and migratory behaviors that are different from those of conventional T cells. Another related myth is that FoxP3(+) regulatory T cell subsets have a fixed trafficking behavior from the time they are generated in the thymus. The recent progress in trafficking receptors and migratory behavior of FoxP3(+) Tregs is reviewed here and the validity of these myths is examined.
引用
收藏
页码:151 / 159
页数:9
相关论文
共 125 条
  • [1] A new distance for high level RNA secondary structure comparison
    Allali, J
    Sagot, MF
    [J]. IEEE-ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS, 2005, 2 (01) : 3 - 14
  • [2] C-C chemokine receptor 4 expression defines a major subset of circulating nonintestinal memory T cells of both Th1 and Th2 potential
    Andrew, DP
    Ruffing, N
    Kim, CH
    Miao, WY
    Heath, H
    Li, Y
    Murphy, K
    Campbell, JJ
    Butcher, EC
    Wu, LJ
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 166 (01) : 103 - 111
  • [3] Andrew DP, 1998, J IMMUNOL, V161, P5027
  • [4] Phenotype, localization, and mechanism of suppression of CD4+CD25+ human thymocytes
    Annunziato, F
    Cosmi, L
    Liotta, F
    Lazzeri, E
    Manetti, R
    Vanini, V
    Romagnani, P
    Maggi, E
    Romagnani, S
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03) : 379 - 387
  • [5] In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines
    Ansel, KM
    McHeyzer-Williams, LJ
    Ngo, VN
    McHeyzer-Williams, MG
    Cyster, JG
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (08) : 1123 - 1134
  • [6] Azuma T, 2003, CANCER RES, V63, P4516
  • [7] Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC
    Baba, M
    Imai, T
    Nishimura, M
    Kakizaki, M
    Takagi, S
    Hieshima, K
    Nomiyama, H
    Yoshie, O
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (23) : 14893 - 14898
  • [8] CCR5+ and CXCR3+ T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions
    Balashov, KE
    Rottman, JB
    Weiner, HL
    Hancock, WW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) : 6873 - 6878
  • [9] The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3
    Bennett, CL
    Christie, J
    Ramsdell, F
    Brunkow, ME
    Ferguson, PJ
    Whitesell, L
    Kelly, TE
    Saulsbury, FT
    Chance, PF
    Ochs, HD
    [J]. NATURE GENETICS, 2001, 27 (01) : 20 - 21
  • [10] Foxp3 interacts with nuclear factor of activated T cells and NF-κB to repress cytokine gene expression and effector functions of T helper cells
    Bettelli, E
    Dastrange, M
    Oukka, M
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (14) : 5138 - 5143